Neuren Pharmaceuticals reported AUD332.23M in Current Assets for its fiscal semester ending in December of 2025.





Current Assets Change Date
Akebia Therapeutics USD 220.78M 8.77M Sep/2026
Alaunos Therapeutics USD 666K 304K Jun/2026
Avita Medical AUD 28.39M 7.1M Jun/2026
Clinuvel Pharmaceuticals AUD 261.38M 1.59M Dec/2025
Dianthus Therapeutics USD 856.04M 41.5M Sep/2026
Genetic Signatures AUD 42.96M 5.02M Dec/2025
Ionis Pharmaceuticals USD 2.36B 129.77M Sep/2026
Medical Developments International AUD 33.75M 1.79M Dec/2025
Neuren Pharmaceuticals AUD 332.23M 11.98M Dec/2025
Organon & Co USD 5.37B 258M Sep/2026
PYC Therapeutics AUD 153.74M 23.79M Dec/2025
Starpharma Holdings AUD 24.24M 1.68M Dec/2025
Tectonic Therapeutic USD 231.1M 8.79M Jun/2026
Telix Pharmaceuticals AUD 488.02M 157.74M Jun/2026
Viatris USD 10.3B 242.1M Sep/2026
Xeris Pharmaceuticals USD 289.26M 14.51M Sep/2026